MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-18-0170858
VHB Medi Sciences Limited - pharma in Kandivlai West, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹159.28 Cr
▲ 14% YoY
Net profit · FY 2025
₹11.97 Cr
Net margin 7.5%
EBITDA · FY 2025
₹23.13 Cr
EBITDA margin 14.5%
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹12.75 Cr
Issued & subscribed
Open charges
₹4.9 Cr
Satisfied ₹185.51 Cr
Company age
19 yrs
Est. 2007
Employees · EPFO
406
Provident fund records
About VHB Medi Sciences Limited
Data last updated:
VHB Medi Sciences Limited is a public limited company based in Kandivlai West, Maharashtra, India, a subsidiary of Neon Laboratories Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 September 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24232MH2007PLC174054. Its GSTIN is 27AACCV5903E2ZG (Maharashtra). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹12.75 Cr. It is led by directors including Ashokkumar Keshrimal Jain (Whole-Time Director) and Rahul Ashokkumar Jain.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 30 A Government Industrial Estate, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹159.28 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹11.97 Cr (net margin 7.5%) and EBITDA of ₹23.13 Cr (EBITDA margin 14.5%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 10% over five years.
The company has about 406 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: VHB Life Sciences. As per MCA filings, the company has open charges of ₹4.9 Cr and satisfied charges of ₹185.51 Cr on record. Court records list 10 cases involving the company, including 8 filed by the company and 2 filed against it; 3 cases are pending. The company has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹12.7 Cr; the latest was in October 2011. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 5 smaller; the largest is Laboratoires Griffon Private Limited with revenue of ₹161.12 Cr.
VHB Medi Sciences Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0170858). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vhbgroup.com.
Company details
CIN U24232MH2007PLC174054
Registration Number 174054
Incorporation Date 12 September 2007
ROC Mumbai
Listing Status Unlisted
Company Status Active
Parent Company Neon Laboratories Limited
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-18-0170858
Key People
Ashokkumar Keshrimal Jain Whole-Time Director Rahul Ashokkumar Jain Director Uttamchand Kesharimal Jain Director Recognitions & Rankings of VHB Medi Sciences
Contact details
VHB Medi Sciences Limited's registered office is in Kandivlai West, Maharashtra. Its website is vhbgroup.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address30 A Government Industrial Estate, Charkop Kandivali (West) Mumbai Maharashtra India Pin 400067, Kandivlai West, Maharashtra, India – 400067
- IndustryPharma, Drug Formulation & Development
To see the full contact details of VHB Medi Sciences Limited, buy the company report.
Comprehensive company report
VHB Medi Sciences Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
VHB Medi Sciences operates one associated brand: VHB Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Generics and APIs are manufactured across therapeutic segments. | vhbgroup.com |
Business activity
The main business activity of VHB Medi Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of VHB Medi Sciences Limited, buy the company report.
Financials of VHB Medi Sciences Limited
FY 2025 filings availableVHB Medi Sciences Limited reported revenue of ₹159.28 Cr (up 14% YoY) for FY 2025.
Revenue · FY 2025
₹159.28 Cr ▲ 14%
Net profit · FY 2025
₹11.97 Cr margin 7.5%
EBITDA · FY 2025
₹23.13 Cr margin 14.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 5%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▲ 1%
3 years · compounded
▼ 13%
5 years · compounded
▲ 13%
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 14% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹23.13 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.97 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.5% | ||||
| Net Profit Margin | 7.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of VHB Medi Sciences Limited, buy the company report.
Board of directors of VHB Medi Sciences Limited
VHB Medi Sciences has 4 current directors and 15 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Ashokkumar Jain Also directs: Surajlok Chemicals Private Limited, VHB Life Sciences Limited, Sndev Healthcare Limited and 1 more | Director | 27 Sep 2012 | 14 Years 1 Months | Current |
| Uttamchand Kesharimal Jain Also directs: Neon Laboratories Limited, Axiommax Oncology Private Limited, VHB Pharmaceuticals Private Limited and 5 more | Director | 27 Sep 2012 | 14 Years 1 Months | Current |
| Ashokkumar Keshrimal Jain Also directs: Neon Laboratories Limited, Axiommax Oncology Private Limited, Surajlok Chemicals Private Limited and 3 more | Whole-Time Director | 27 Sep 2012 | 14 Years 1 Months | Current |
| Pravin Keshrimal Jain Also directs: Neon Laboratories Limited, VHB Pharmaceuticals Private Limited, Yog Divakar Realtors and Investors Private Limited and 5 more | Director | 27 Sep 2012 | 14 Years 1 Months | Current |
Peer comparison
VHB Medi Sciences Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Laboratoires Griffon Private Limited | ₹161.12 Cr (FY 2024) | 8.0% | Kolkata, West Bengal, India | |||
| Elysium Pharmaceuticals Ltd | ₹159.55 Cr (FY 2024) | -26.0% | Vadodara, Gujarat, India | |||
| VHB Medi Sciences Limitedthis company | ₹159.28 Cr (FY 2025) | ₹11.97 Cr | 7.5% | 14.0% | 406 | Kandivlai West, Maharashtra, India |
| Jenburkt Pharmaceuticals Ltd | ₹158.41 Cr (FY 2025) | 8.0% | Mumbai, Maharashtra, India | |||
| Wardex Pharmaceuticals Private Limited | ₹158.1 Cr (FY 2025) | 8.0% | Chennai, Tamil Nadu, India | |||
| Nitin Lifesciences Limited | ₹157.19 Cr (FY 2025) | 7.0% | Paonta Sahib, Himachal Pradesh, India | |||
| Wings Pharmaceuticals Pvt Ltd | ₹155.72 Cr (FY 2025) | 12.0% | New Delhi, Delhi, India | |||
| Combitic Global Caplet Private Limited | ₹154.55 Cr (FY 2025) | 37.0% | New Delhi, Delhi, India |
To see the full peer comparison of VHB Medi Sciences Limited, buy the company report.
Auditor
VHB Medi Sciences Limited is audited by RAJU MORE & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJU MORE & ASSOCIATES | FY 2024 | 127718W |
Shareholding
The shareholding of VHB Medi Sciences Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of VHB Medi Sciences Limited, buy the company report.
Charges & borrowings
Open charges
₹4.9 Cr
Satisfied charges
₹185.51 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Apr 2009 | 10155427 | Others | ₹4.9 Cr | Open | |
| 23 Oct 2010 | 10258353 | Bank of Baroda | ₹2 Cr | Satisfied | |
| 19 Dec 2009 | 10200373 | Bank of Baroda | ₹7.15 Lakh | Satisfied | |
| 11 Jul 2009 | 10173720 | Bank of Baroda | ₹3 Cr | Satisfied | |
| 09 Apr 2009 | 10155426 | Bank of Baroda | ₹116.34 Cr | Satisfied |
To see the full charge records of VHB Medi Sciences Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
VHB Medi Sciences Limited has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹12.7 Cr; the latest was in October 2011.
Total deals
3
Secondary share transfers
2
Funding round
1
Disclosed funding
₹12.7 Cr
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2011 | Secondary share transfer | Undisclosed | Buyer: Pravin Keshrimal Jain HUF, Neon Laboratories Limited , Uttam Keshrimal Jain HUF, an individual Seller: Vipul R Bhagat Huf, 3 individuals |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: Neon Laboratories Limited , 3 individuals Seller: 4 individuals |
| Dec 2008 | Funding round | ₹12.7 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
VHB Medi Sciences Limited has 10 court cases on record: 8 filed by VHB Medi Sciences, 2 filed against it. 3 cases are pending and 7 are disposed.
Total cases
10
Filed by the company
8
Filed against the company
2
Pending
3
Disposed
7
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 5 | 1 | 1 |
| District courts | 4 | 0 | 2 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed by the company against Athena Packtech LLP | Pending |
| High Court | Arbitration matter | Filed by the company against Intas Pharmaceuticals Limited | Disposed |
| High Court for State of Telangana | Writ petition | Filed by the company against Government of Andhra Pradesh, Rep.By Its Principal | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Commercial suit | Filed by the company against Athena Packtech LLP and 3 others | Pending |
| High Court of Uttarakhand | Court case (WPMS) | Filed by the company against State of Uttarakhand | Pending |
To see the full case history of VHB Medi Sciences Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
VHB Medi Sciences Limited was last rated by Crisil on 30 Jul 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 30 Jul 2020 |
To see the full credit ratings and regulatory alerts of VHB Medi Sciences Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for VHB Medi Sciences Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
VHB Medi Sciences Limited has a workforce of 406 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.
Employee count
406
Active EPFO establishments
2
Employee growth
38.1%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 406 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 | |
| FY 2015-16 | |
| FY 2014-15 |
To see the full employee and EPFO history of VHB Medi Sciences Limited, buy the company report.
GST
VHB Medi Sciences has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCV5903E2ZG | Maharashtra | Active | 03 Jul 2021 |
| 05AACCV5903E1ZN | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of VHB Medi Sciences Limited, buy the company report.
Recent activity
VHB Medi Sciences Limited has 15 board changes on record since 2012: 5 appointments and 10 cessations. The latest: Rahul Ashokkumar Jain ceased to be Cfo(Kmp) on 01 Jul 2019.
AGM
Vhb Medi Sciences Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Filing
Vhb Medi Sciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Others of Rs. 4.90 Cr registered on 09 Apr 2009 with Charge ID 10155427 was modified on 07 Apr 2021.
Charges
A charge registered on 19 Dec 2009 via Charge ID 10200373 with Bank Of Baroda was fully satisfied on 18 Nov 2019.
Charges
A charge registered on 09 Apr 2009 via Charge ID 10155426 with Bank Of Baroda was fully satisfied on 18 Nov 2019.
Charges
A charge registered on 23 Oct 2010 via Charge ID 10258353 with Bank Of Baroda was fully satisfied on 05 Nov 2019.
Charges
A charge registered on 11 Jul 2009 via Charge ID 10173720 with Bank Of Baroda was fully satisfied on 05 Nov 2019.
Charges
A charge registered on 07 Jun 2008 via Charge ID 10113095 with Bank Of Baroda was fully satisfied on 05 Nov 2019.
Ceased
Rahul Ashokkumar Jain ceased to be Cfo(Kmp).
Appointed
Rohan Jain Ashok was appointed as CFO.
Ceased
Ashokkumar Keshrimal Jain ceased to be Director.
Ceased
Kishor Champalal Solanki ceased to be Director.
19 earlier events are in the company report.
Frequently asked questions
VHB Medi Sciences is an active public limited company based in Kandivlai West, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 September 2007 (19+ years old) and is registered under CIN U24232MH2007PLC174054.
VHB Medi Sciences has 4 current directors:
- Ashokkumar Keshrimal Jain - Whole-Time Director
- Rahul Ashokkumar Jain - Director
- Uttamchand Kesharimal Jain - Director
- Pravin Keshrimal Jain - Director
The latest financial statements of VHB Medi Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of VHB Medi Sciences is 27AACCV5903E2ZG, registered in Maharashtra. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 05AACCV5903E1ZN (Uttarakhand).
The CIN (Corporate Identification Number) of VHB Medi Sciences is U24232MH2007PLC174054. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
VHB Medi Sciences has 10 court cases on record: 8 filed by the company and 2 filed against it. 3 are pending. Most are in the high courts.
VHB Medi Sciences was incorporated on 12 September 2007, making it 19+ years old. It is registered with the Registrar of Companies, Mumbai.
VHB Medi Sciences has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹12.7 Cr; the latest was in October 2011.
The peers of VHB Medi Sciences by revenue are Laboratoires Griffon Private Limited, Elysium Pharmaceuticals Ltd, Jenburkt Pharmaceuticals Ltd, Wardex Pharmaceuticals Private Limited, Nitin Lifesciences Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rahul Ashokkumar Jain ceased to be Cfo(Kmp) on 01 Jul 2019. Rohan Jain Ashok was appointed as CFO on 01 Jul 2019. Ashokkumar Keshrimal Jain ceased to be Director on 01 Apr 2019. VHB Medi Sciences has 15 board changes on record in total.
Yes, VHB Medi Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-18-0170858).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages